Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics and clinical impact of pegaspargase in pediatric ALL
ChiCTR2400080371Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jan 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: Pegaspargase trough concentration, Pegaspargase clearance and 2 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on ChiCTR2400080371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080371.